Skip to content

Development of a mobile mindfulness smartphone app for post-traumatic stress disorder and alcohol use problems for veterans: Beta test results and study protocol for a pilot randomized controlled trial.

Jordan P Davis, Eric R Pedersen, Brian Borsari, Sarah Bowen, Jason E. Owen, Angeles Sedano, Reagan Fitzke, Joannalyn Delacruz, Denise D Tran, Keegan Buch, Shaddy K. Saba, Liv Canning, John Bunyi

Contemporary Clinical Trials April 12, 2023 DOI: 10.1016/j.cct.2023.107181 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Pilot randomized controlled trial protocol with a completed beta test (Phase 2) and methods description Peer reviewed
Sample size 16
Population Post-9/11 veterans who screened positive for PTSD and alcohol use disorder and were not currently receiving treatment
Duration 30-day beta test; pilot RCT will follow participants for 3 months
Measures PTSD Checklist, self-reported alcohol use, Perceived Stress Scale, Penn Alcohol Craving Scale, Emotion Regulation Questionnaire
Topics Addiction Meditation PTSD
Keywords Humans Alcoholism Pilot projects Stress disorders, post-traumatic Veterans Mobile applications Clinical trial Va Mobile health
Registration NCT04769986
Key findings In a 16-veteran beta test, the Mind Guide app was associated with improvements over 30 days in PTSD symptoms, alcohol use frequency and problems, craving, perceived stress, and emotion regulation, with effect sizes ranging from d = -0.44 to d = -1.22. The authors describe these results as promising and are proceeding to a pilot randomized controlled trial of 200 veterans with three-month follow-up.

Abstract

Background: Post-traumatic stress disorder (PTSD) and alcohol use disorder (AUD) are highly prevalent, and co-occurring among post-9/11 veterans. Mobile health (mHealth) applications, specifically those focused on mindfulness-based techniques, may be an effective avenue to intervene with veterans who cannot or will not seek care at traditional in-person settings. Thus, to address areas of improvement in mHealth for veterans, we developed Mind Guide and prepared it for testing in a pilot randomized controlled trial (RCT) with veterans.

Methods: We have completed phase 1 (treatment development) and Phase 2 (beta test) of our mobile mHealth app, Mind Guide. In this paper we describe the methods for Phase 1 as well as results for our beta test (n = 16; inclusion criteria included screen for PTSD, AUD, a post-9/11 veteran, and not currently receiving treatment) for Mind Guide as well as outline procedures for our pilot RCT of Mind Guide (Phase 3). The PTSD Checklist, self-reported alcohol use, the Perceived Stress Scale, Penn Alcohol Craving Scale, and the Emotion Regulation Questionnaire were used.

Results: Results of our beta test of Mind Guide show promising past 30 day effects on PTSD (d = -1.12), frequency of alcohol use (d = -0.54), and alcohol problems (d = -0.44), and related mechanisms of craving (d = -0.53), perceived stress (d = -0.88), and emotion regulation (d = -1.22).

Conclusion: Our initial beta-test of Mind Guide shows promise for reducing PTSD and alcohol related problems among veterans. Recruitment is ongoing for our pilot RCT in which 200 veterans will be recruited and followed up for 3 months. Clinicaltrials: gov Identifier: NCT04769986.

Comparable studies

Other randomized controlled trials on PTSD, most cited first.

Study Year Design Participants
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Patients with severe PTSD, including those with comorbidities such as dissociation,... 2021 Randomized controlled trial n = 90
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Patients with chronic post-traumatic stress disorder refractory to both psychotherapy... 2010 Randomized controlled trial n = 20
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Military veterans and first responders aged 18 or older with chronic PTSD lasting 6... 2018 Randomized, double-blind, dose-response, phase 2 clinical trial n = 26
A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD) Patients with treatment-resistant PTSD 2012 Randomized controlled trial n = 12

Citations in the library

Explore topics